Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.450
+0.130 (9.85%)
At close: Feb 6, 2026, 4:00 PM EST
1.280
-0.170 (-11.72%)
Pre-market: Feb 9, 2026, 4:21 AM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $60.95 million as of February 9, 2026. Its market cap has increased by 42.77% in one year.
Market Cap
60.95M
Enterprise Value
59.33M
1-Year Change
42.77%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $60.95M, an increase of 3,328.76%. That is a compound annual growth rate of 191.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 60.95M | 3.45% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 44.18M |
| CEL-SCI | 43.27M |
| Plus Therapeutics | 42.46M |
| Lisata Therapeutics | 40.49M |
| INmune Bio | 40.28M |
| Telomir Pharmaceuticals | 40.23M |
| Lite Strategy | 39.71M |
| NextCure | 39.63M |